• Something wrong with this record ?

A cross-sectional, prospective ocular motor study in 72 patients with Niemann-Pick disease type C

T. Bremova-Ertl, L. Abel, M. Walterfang, E. Salsano, A. Ardissone, V. Malinová, M. Kolníková, J. Gascón Bayarri, A. Reza Tavasoli, M. Reza Ashrafi, Y. Amraoui, E. Mengel, SA. Kolb, A. Brecht, S. Bardins, M. Strupp

. 2021 ; 28 (9) : 3040-3050. [pub] 20210712

Language English Country Great Britain

Document type Journal Article, Research Support, Non-U.S. Gov't

Persistent link   https://www.medvik.cz/link/bmc22003805

OBJECTIVE: To characterize ocular motor function in patients with Niemann-Pick disease type C (NPC). METHODS: In a multicontinental, cross-sectional study we characterized ocular-motor function in 72 patients from 12 countries by video-oculography. Interlinking with disease severity, we also searched for ocular motor biomarkers. Our study protocol comprised reflexive and self-paced saccades, smooth pursuit, and gaze-holding in horizontal and vertical planes. Data were compared with those of 158 healthy controls (HC). RESULTS: Some 98.2% of patients generated vertical saccades below the 95% CI of the controls' peak velocity. Only 46.9% of patients had smooth pursuit gain lower than that of 95% CI of HC. The involvement in both downward and upward directions was similar (51°/s (68.9, [32.7-69.3]) downward versus 78.8°/s (65.9, [60.8-96.8]) upward). Horizontal saccadic peak velocity and latency, vertical saccadic duration and amplitude, and horizontal position smooth pursuit correlated best to disease severity. Compensating strategies such as blinks to elicit saccades, and head and upper body movements to overcome the gaze palsy, were observed. Vertical reflexive saccades were more impaired and slower than self-paced ones. Gaze-holding was normal. Ocular-motor performance depended on the age of onset and disease duration. CONCLUSIONS: This is the largest cohort of NPC patients investigated for ocular-motor function. Vertical supranuclear saccade palsy is the hallmark of NPC. Vertical upward and downward saccades are equally impaired. Horizontal saccadic peak velocity and latency, vertical saccadic duration and amplitude, and horizontal position smooth pursuit can be used as surrogate parameters for clinical trials. Compensating strategies can contribute to establishing a diagnosis.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22003805
003      
CZ-PrNML
005      
20220127145837.0
007      
ta
008      
220113s2021 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1111/ene.14955 $2 doi
035    __
$a (PubMed)34096670
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Bremova-Ertl, Tatiana $u Department of Neurology, University Hospital Bern (Inselspital) and University of Bern, Bern, Switzerland $u Center for Rare Diseases, University Hospital Bern (Inselspital) and University of Bern, Bern, Switzerland
245    12
$a A cross-sectional, prospective ocular motor study in 72 patients with Niemann-Pick disease type C / $c T. Bremova-Ertl, L. Abel, M. Walterfang, E. Salsano, A. Ardissone, V. Malinová, M. Kolníková, J. Gascón Bayarri, A. Reza Tavasoli, M. Reza Ashrafi, Y. Amraoui, E. Mengel, SA. Kolb, A. Brecht, S. Bardins, M. Strupp
520    9_
$a OBJECTIVE: To characterize ocular motor function in patients with Niemann-Pick disease type C (NPC). METHODS: In a multicontinental, cross-sectional study we characterized ocular-motor function in 72 patients from 12 countries by video-oculography. Interlinking with disease severity, we also searched for ocular motor biomarkers. Our study protocol comprised reflexive and self-paced saccades, smooth pursuit, and gaze-holding in horizontal and vertical planes. Data were compared with those of 158 healthy controls (HC). RESULTS: Some 98.2% of patients generated vertical saccades below the 95% CI of the controls' peak velocity. Only 46.9% of patients had smooth pursuit gain lower than that of 95% CI of HC. The involvement in both downward and upward directions was similar (51°/s (68.9, [32.7-69.3]) downward versus 78.8°/s (65.9, [60.8-96.8]) upward). Horizontal saccadic peak velocity and latency, vertical saccadic duration and amplitude, and horizontal position smooth pursuit correlated best to disease severity. Compensating strategies such as blinks to elicit saccades, and head and upper body movements to overcome the gaze palsy, were observed. Vertical reflexive saccades were more impaired and slower than self-paced ones. Gaze-holding was normal. Ocular-motor performance depended on the age of onset and disease duration. CONCLUSIONS: This is the largest cohort of NPC patients investigated for ocular-motor function. Vertical supranuclear saccade palsy is the hallmark of NPC. Vertical upward and downward saccades are equally impaired. Horizontal saccadic peak velocity and latency, vertical saccadic duration and amplitude, and horizontal position smooth pursuit can be used as surrogate parameters for clinical trials. Compensating strategies can contribute to establishing a diagnosis.
650    _2
$a průřezové studie $7 D003430
650    _2
$a pohyby očí $7 D005133
650    _2
$a lidé $7 D006801
650    12
$a Niemannova-Pickova nemoc typu C $7 D052556
650    _2
$a prospektivní studie $7 D011446
650    _2
$a sakadické oční pohyby $7 D012438
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Abel, Larry $u Optometry & Vision Science, School of Medicine, Deakin University, Waurn Ponds, Victoria, Australia
700    1_
$a Walterfang, Mark $u Neuropsychiatry Unit, Royal Melbourne Hospital, Parkville, Victoria, Australia $u Melbourne Neuropsychiatry Centre, University of Melbourne & NorthWestern Mental Health, Parkville, Victoria, Australia
700    1_
$a Salsano, Ettore $u Unit of Rare Neurodegenerative and Neurometabolic Diseases, Fondazione IRCCS Istituto Neurologico "Carlo Besta", Milan, Italy
700    1_
$a Ardissone, Anna $u Unit of Rare Neurodegenerative and Neurometabolic Diseases, Fondazione IRCCS Istituto Neurologico "Carlo Besta", Milan, Italy
700    1_
$a Malinová, Věra $u Department of Pediatrics and Adolescence Medicine, First Faculty of Medicine, General University Hospital Prague, Charles University, Prague, Czech Republic
700    1_
$a Kolníková, Miriam $u Department of Child Neurology, Comenius University Children's Hospital, Bratislava, Slovak Republic
700    1_
$a Gascón Bayarri, Jordi $u Department of Neurology, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Spain
700    1_
$a Reza Tavasoli, Ali $u Pediatric Neurology Division, Children's Medical Center, Pediatric Center of Excellence, Myelin Disorders Clinic, Tehran University of Medical Sciences, Tehran, Iran
700    1_
$a Reza Ashrafi, Mahmoud $u Pediatric Neurology Division, Children's Medical Center, Pediatric Center of Excellence, Myelin Disorders Clinic, Tehran University of Medical Sciences, Tehran, Iran
700    1_
$a Amraoui, Yasmina $u SphinCS Gmbh, Clinical Science for LSD, Hochheim, Germany
700    1_
$a Mengel, Eugen $u SphinCS Gmbh, Clinical Science for LSD, Hochheim, Germany
700    1_
$a Kolb, Stefan A $u Actelion, a Janssen company of Johnson & Johnsons, Bern, Switzerland
700    1_
$a Brecht, Andreas $u Actelion, a Janssen company of Johnson & Johnsons, Bern, Switzerland
700    1_
$a Bardins, Stanislavs $u German Center for Vertigo and Balance Disorders and Department of Neurology, University Hospital Munich, Campus Grosshadern, Ludwig-Maximilians-University Munich, Munich, Germany
700    1_
$a Strupp, Michael $u German Center for Vertigo and Balance Disorders and Department of Neurology, University Hospital Munich, Campus Grosshadern, Ludwig-Maximilians-University Munich, Munich, Germany
773    0_
$w MED00001629 $t European journal of neurology $x 1468-1331 $g Roč. 28, č. 9 (2021), s. 3040-3050
856    41
$u https://pubmed.ncbi.nlm.nih.gov/34096670 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20220113 $b ABA008
991    __
$a 20220127145833 $b ABA008
999    __
$a ok $b bmc $g 1751310 $s 1154954
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 28 $c 9 $d 3040-3050 $e 20210712 $i 1468-1331 $m European journal of neurology $n Eur J Neurol $x MED00001629
LZP    __
$a Pubmed-20220113

Find record

Citation metrics

Archiving options